Skip to main content
. 2021 Jul;154(1):121–131. doi: 10.4103/ijmr.IJMR_661_20

Table III.

Total costs, health outcomes and cost-effectiveness of implementing Mycobacterium indicus pranii (MIP) vaccination in National Leprosy Eradication Programme (NLEP), over a five-year period in India

Intervention Total cost (₹ in million) QALYs lived (₹ in million) ICER in ₹ per QALYs gained Discounted


Non-discounted Discounted Non-discounted Discounted
MDT + MIP vaccination for all new patients + MIP vaccination for contacts of new patients 21,151 19,939 6,772 6,385 73,790
MDT alone for new patients and follow up + follow up of contacts of new patients 18,688 17,618 6,772 6,385

The dollar equivalent of ICER per QALY’s gained is $1054 (approximate 2019 conversion rate). MDT, multidrug therapy; ICER, Incremental cost-effectiveness ratio; QALY, Quality Adjusted Life Years